Day: October 16, 2020

TORONTO, Oct. 16, 2020 (GLOBE NEWSWIRE) — October 16, 2020 — Noront Resources Ltd. (“Noront” or the “Company”) (TSX Venture: NOT) is pleased to provide an update of activities for interested stakeholders.InfrastructureThe Company was pleased to see the recent request for proposals (RFP) for the Northern Road Link Environmental Assessment (NRL Road EA) and associated engineering for last leg of the North-South all season road network to the Ring of Fire. All sections of the road are now progressing through the EA process with First Nation proponents. This portion of the road will link the Marten Falls Community Access Road and the Webequie Supply Road to the Ring of Fire.PermittingNoront has reinitiated its permitting activities for the Eagle’s Nest nickel-copper-platinum-palladium deposit. A Draft Environmental Assessment (Mine...

NEW YORK, Oct. 16, 2020 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, announced the initiation of an Energy Performance Contracting program for McKeesport Area School District (MASD), located in McKeesport, Pennsylvania. By creating projected savings of $7.8 million in energy and operating costs, ABM’s custom solution empowers MASD leadership to reallocate funds to critical improvements for their learning environment, including indoor air quality.“To really help schools today, facility solutions have to also be funding solutions,” said Scott Giacobbe, ABM’s Chief Revenue Officer. “I’m proud of our teams’ ability to find opportunities for energy and operational savings, and then use that to improve learning spaces within a model of good fiscal stewardship, like we were able to do with McKeesport.”The...

NEW YORK, 16 oct. 2020 (GLOBE NEWSWIRE) — Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) annonce aujourd’hui que sa filiale Calyxt, Inc. (NASDAQ: CLXT), une société de technologie dédiée aux plantes, a conclu des accords définitifs avec des investisseurs institutionnels portant sur la souscription de 3.750.000 actions ordinaires de Calyxt, au prix de 4,00 dollars par action, dans le cadre d’une offre directe enregistrée auprès de la Securities and Exchange Commission aux États-Unis (la « SEC »). Cellectis s’est engagée à souscrire 1.250.000 actions dans le cadre de l’offre et détiendra à l’issue de l’offre 64,7 % du capital et des droits de vote de Calyxt (contre approximativement 68,22 % actuellement).La clôture de l’offre devrait avoir lieu autour du 20 octobre 2020, sous réserve des conditions de réalisation...

NEW YORK, Oct. 16, 2020 (GLOBE NEWSWIRE) — Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) announced today that its majority-owned subsidiary Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has entered into definitive agreements with institutional investors for the purchase and sale of 3,750,000 shares of Calyxt’s common stock, at a purchase price of $4.00 per share, in a registered direct offering. Cellectis subscribed to purchase 1,250,000 shares in the offering. Following the registered direct offering, Cellectis will own approximately 64.7% of Calyxt’s outstanding shares of common stock.The closing of the offering is expected to occur on or about October 20, 2020, subject to the satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the exclusive placement agent for the transaction.The...

GARDEN CITY, N.Y., Oct. 16, 2020 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors, today announced new in vitro and in vivo preclinical data that suggest the Company’s innovative gNO-based treatment may treat lung cancer locally and its metastases systemically, potentially via stimulation of an anti-tumor immune response. These data were included in a presentation by Hila Confino, PhD of Beyond Air at the International Association for the Study of Lung Cancer’s (IASLC) North America Conference on Lung Cancer 2020 (NACLC 2020), which is being held...

CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitisRecommendation based on pivotal trial that showed Dupixent plus topical corticosteroids (TCS) significantly improved measures of overall disease severity, skin clearance, itch and health-related quality of life measures, compared to TCS aloneData further reinforce the well-established safety profile of Dupixent in adult and adolescent atopic dermatitis patientsDupixent would be the first biologic medicine available in the EU to treat this patient group and remains the only biologic medicine approved in moderate-to-severe atopic dermatitis for adolescents and adultsPARIS and TARRYTOWN, NY – October 16, 2020 – The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion...

Le CHMP recommande l’approbation de Dupixent® (dupilumab) pour le traitement de la dermatite atopique sévère de l’enfant âgé de 6 à 11 ansRecommandation fondée sur les résultats d’un essai clinique ayant montré que Dupixent en association avec des corticoïdes topiques a permis d’observer des améliorations significatives de la sévérité globale de la maladie, de la cicatrisation de la peau, des démangeaisons et du score de la qualité de vie en lien avec la santé, comparativement aux corticoïdes topiques seulement.Les données confortent le profil de sécurité bien établi de Dupixent observé chez les patients adultes et adolescents souffrant de dermatite atopique.  Dupixent pourrait devenir le premier médicament biologique disponible dans l’UE pour ce groupe de patients et reste le seul médicament biologique approuvé pour le traitement de...

VANCOUVER, British Columbia, Oct. 16, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announced today that it has agreed to an extension of terms for its promotional service agreement with Sandoz Canada Inc. (“Sandoz”) on tacrolimus immediate-release (“Tacrolimus IR”) to December 31st, 2021. Aequus began promotional efforts in December 2015 for Sandoz’s generic tacrolimus, and has since achieved over 10x growth of the product in Canada through increased brand awareness, new patient adoption programs, and leveraging conversion experience and relationships across provinces.“We believe there continues to be considerable room for growth over the next twelve months for tacrolimus IR, as we plan continued support for patients and physicians regarding the use of this high-quality...

TAMPA, Fla., Oct. 16, 2020 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), an InsurTech company with operations in insurance, software development and real estate, will hold a conference call on Thursday, November 5, 2020, at 4:45 p.m. Eastern time to discuss results for the third quarter ended September 30, 2020. Financial results will be issued in a press release after the close of the market on the same day.HCI management will host the presentation, followed by a question and answer period.Interested parties can listen to the live presentation by dialing the listen-only number below or by clicking the webcast link available on the Investor Information section of the company’s website at www.hcigroup.com.Date: Thursday, November 5, 2020Time: 4:45 p.m. Eastern time (1:45 p.m. Pacific time)Listen-only toll-free number: (844)...

VANCOUVER, British Columbia, Oct. 16, 2020 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (“Amerigo” or the “Company”) (TSX: ARG) is pleased to announce Q3-2020 production results from Minera Valle Central (“MVC”), the Company’s 100% owned operation located near Rancagua, Chile.MVC produced 14.7 million pounds (“M lbs”) of copper at a cash cost of US$1.80 per pound (“/lb”) and 0.4 M lbs of molybdenum.MVC’s copper production from fresh and Cauquenes tailings increased 13% compared to Q2-2020 and was 9% higher than the Q3-2020 guidance provided in the Q2-2020 production results.Q3-2020 copper production was positively impacted by an increase in tonnage processed at Cauquenes as more water became available in MVC following a return to almost normal rainfall levels. MVC had reduced Cauquenes tonnage processing...